MedPacto (Korea) Market Value
| 235980 Stock | KRW 5,350 650.00 13.83% |
| Symbol | MedPacto |
MedPacto 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MedPacto's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MedPacto.
| 01/06/2023 |
| 11/26/2024 |
If you would invest 0.00 in MedPacto on January 6, 2023 and sell it all today you would earn a total of 0.00 from holding MedPacto or generate 0.0% return on investment in MedPacto over 690 days. MedPacto is related to or competes with ALTEOGEN. MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoim... More
MedPacto Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MedPacto's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MedPacto upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 18.66 | |||
| Value At Risk | (5.49) | |||
| Potential Upside | 3.93 |
MedPacto Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedPacto's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MedPacto's standard deviation. In reality, there are many statistical measures that can use MedPacto historical prices to predict the future MedPacto's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | (0.45) |
MedPacto Backtested Returns
MedPacto has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11% return per unit of risk over the last 3 months. MedPacto exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MedPacto's Risk Adjusted Performance of (0.08), mean deviation of 2.22, and Standard Deviation of 3.38 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.92, which conveys possible diversification benefits within a given portfolio. MedPacto returns are very sensitive to returns on the market. As the market goes up or down, MedPacto is expected to follow. At this point, MedPacto has a negative expected return of -0.39%. Please make sure to verify MedPacto's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if MedPacto performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.66 |
Good predictability
MedPacto has good predictability. Overlapping area represents the amount of predictability between MedPacto time series from 6th of January 2023 to 17th of December 2023 and 17th of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MedPacto price movement. The serial correlation of 0.66 indicates that around 66.0% of current MedPacto price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 8 M |
MedPacto lagged returns against current returns
Autocorrelation, which is MedPacto stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MedPacto's stock expected returns. We can calculate the autocorrelation of MedPacto returns to help us make a trade decision. For example, suppose you find that MedPacto has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MedPacto regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MedPacto stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MedPacto stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MedPacto stock over time.
Current vs Lagged Prices |
| Timeline |
MedPacto Lagged Returns
When evaluating MedPacto's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MedPacto stock have on its future price. MedPacto autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MedPacto autocorrelation shows the relationship between MedPacto stock current value and its past values and can show if there is a momentum factor associated with investing in MedPacto.
Regressed Prices |
| Timeline |
Other Information on Investing in MedPacto Stock
MedPacto financial ratios help investors to determine whether MedPacto Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedPacto with respect to the benefits of owning MedPacto security.